Nano-X Imaging Reports Q1 2026 Revenue Miss and Withdraws Outlook
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Source: seekingalpha
- Revenue Shortfall: Nano-X Imaging reported Q1 2026 revenue of $4.3 million, missing consensus by $240,000, despite a year-over-year growth of approximately 54%, leading to a premarket stock drop of about 24% as investor expectations were not met.
- Widening Net Loss: The company's net loss widened by approximately 8% year-over-year to $14.3 million, primarily due to a $900,000 increase in operating expenses, even as its gross loss margin improved from 108% to 60%, indicating ongoing cost control challenges.
- Negative Cash Flow: The operational cash flow turned negative at $14.0 million in Q1, with cash and cash equivalents declining 26% year-over-year to $44.3 million, raising concerns about the company's ability to sustain operations for at least the next 12 months.
- Uncertain Outlook: Nano-X Imaging withdrew its full-year revenue outlook of $35 million, citing variability in system deployments and service executions that could impact revenue recognition timing, further intensifying market doubts about its going concern status.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy NNOX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on NNOX
Wall Street analysts forecast NNOX stock price to rise
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.570
Low
7.00
Averages
7.00
High
7.00
Current: 1.570
Low
7.00
Averages
7.00
High
7.00
About NNOX
Nano-X Imaging Ltd is an Israel-based company that develops a digital X-ray source enabling a cost reduction of imaging systems.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Nano-X Imaging Set to Announce Q1 Earnings on June 25
- Earnings Announcement Date: Nano-X Imaging is set to release its Q1 2023 earnings report on June 25 before the market opens, with investors keenly awaiting the results to assess the company's future growth potential.
- Earnings Expectations: The consensus EPS estimate stands at -$0.14, reflecting a 33.3% year-over-year improvement, indicating the company's efforts to enhance profitability, although it remains in a loss position.
- Revenue Expectations: The consensus revenue estimate is $4.54 million, representing a 61.0% year-over-year increase, which highlights a positive trend in market demand and product sales, potentially laying a foundation for future growth.
- Historical Performance Review: Over the past two years, Nano-X has only beaten EPS estimates 25% of the time and has not exceeded revenue estimates, suggesting that market confidence in its performance still needs to be bolstered.
See More
Class Action Filed Against Nano-X Imaging Ltd. Over Securities Violations
- Class Action Initiation: Pomerantz LLP has filed a class action lawsuit against Nano-X Imaging Ltd. in New Jersey on behalf of investors who purchased securities between March 31, 2025, and April 17, 2026, seeking damages for violations of federal securities laws, highlighting a significant trust crisis among investors regarding the company's management.
- Financial Loss Disclosure: On April 20, 2026, Nano-X reported a Q4 net loss of $33.4 million, including a $17.5 million impairment charge, indicating severe financial challenges during its restructuring process, which may further erode investor confidence.
- Executive Turnover Impact: The announcement of CFO Ran Daniel's resignation effective July 31, 2026, raises concerns about the company's leadership stability, potentially exacerbating market worries about its operational and financial health, which could negatively affect stock performance.
- Stock Price Volatility: Following the earnings report, Nano-X's stock price fell by $0.695, or 24.39%, closing at $2.155, reflecting a pessimistic market sentiment regarding the company's future prospects and possibly prompting further investor withdrawals.
See More
Nano-X Imaging Reports Q1 2026 Revenue Miss and Withdraws Outlook
- Revenue Shortfall: Nano-X Imaging reported Q1 2026 revenue of $4.3 million, missing consensus by $240,000, despite a year-over-year growth of approximately 54%, leading to a premarket stock drop of about 24% as investor expectations were not met.
- Widening Net Loss: The company's net loss widened by approximately 8% year-over-year to $14.3 million, primarily due to a $900,000 increase in operating expenses, even as its gross loss margin improved from 108% to 60%, indicating ongoing cost control challenges.
- Negative Cash Flow: The operational cash flow turned negative at $14.0 million in Q1, with cash and cash equivalents declining 26% year-over-year to $44.3 million, raising concerns about the company's ability to sustain operations for at least the next 12 months.
- Uncertain Outlook: Nano-X Imaging withdrew its full-year revenue outlook of $35 million, citing variability in system deployments and service executions that could impact revenue recognition timing, further intensifying market doubts about its going concern status.
See More
Nano-X Imaging Reports Q1 Earnings with Significant Revenue Growth
- Earnings Highlights: Nano-X Imaging reported a Q1 GAAP EPS of -$0.20, aligning with market expectations, indicating stability in its financial performance.
- Revenue Surge: The company achieved revenue of $4.31 billion in Q1, marking a staggering year-over-year increase of 152736.9%, surpassing analyst forecasts and demonstrating robust business growth momentum.
- Market Reaction: Despite the strong earnings report, Nano-X Imaging's shares fell 3% in after-hours trading, reflecting market caution regarding future growth prospects.
- Investment Outlook: Analysts suggest that while the current stock price is deemed “too cheap to ignore,” investors should remain cautious about timing their entry due to uncertainties surrounding the company's future developments.
See More
Class Action Filed Against Nano-X for Misleading Statements
- Class Action Initiated: Bragar Eagel & Squire, P.C. has filed a class action lawsuit against Nano-X Imaging Ltd. in New Jersey on behalf of investors who purchased securities between March 31, 2025, and April 17, 2026, indicating strong investor dissatisfaction with the company's misleading statements.
- Allegations of Misrepresentation: The lawsuit alleges that Nano-X made false statements regarding operational efficiency and product demand, leading to significantly increased operating expenses and cash burn, which may necessitate restructuring and impairment charges, thereby impacting the company's future financial stability.
- Financial Loss Disclosure: Nano-X reported a net loss of $33.4 million for Q4 2025 on April 20, 2026, including a $17.5 million impairment charge due to restructuring at its Korean chip manufacturing facility, reflecting a deterioration in the company's financial condition.
- Stock Price Volatility: Following the earnings report, Nano-X's stock price plummeted from $2.85 on April 17, 2026, to $2.15, a decline of approximately 25%, indicating market pessimism regarding the company's outlook.
See More
Nano-X Faces Securities Class Action Over Financial Misconduct
- Financial Loss Disclosure: On April 20, 2026, Nano-X reported a quarterly net loss of $33.4 million and a $17.5 million impairment charge, causing its stock to plummet by 24.39% to $2.155, indicating severe deterioration in the company's financial health.
- Rising Operating Expenses: The lawsuit alleges that Nano-X's operating expenses and cash burn escalated significantly at its South Korean manufacturing facility, with management failing to disclose this trend, leading to investor misconceptions about the company's financial stability.
- Lack of Transparency: Nano-X's financial disclosures reportedly misrepresented the true state of cost control, as management's reassurances did not align with actual operational conditions, potentially depriving investors of critical information for informed decision-making.
- Legal Accountability Issues: Under SEC regulations, Nano-X's management had a duty to disclose known trends likely to have a material adverse impact on financial results, and their failure to do so may expose the company to legal liabilities.
See More
Nano-X Imaging Set to Announce Q1 Earnings on June 25
- Earnings Announcement Date: Nano-X Imaging is set to release its Q1 2023 earnings report on June 25 before the market opens, with investors keenly awaiting the results to assess the company's future growth potential.
- Earnings Expectations: The consensus EPS estimate stands at -$0.14, reflecting a 33.3% year-over-year improvement, indicating the company's efforts to enhance profitability, although it remains in a loss position.
- Revenue Expectations: The consensus revenue estimate is $4.54 million, representing a 61.0% year-over-year increase, which highlights a positive trend in market demand and product sales, potentially laying a foundation for future growth.
- Historical Performance Review: Over the past two years, Nano-X has only beaten EPS estimates 25% of the time and has not exceeded revenue estimates, suggesting that market confidence in its performance still needs to be bolstered.
See More
Class Action Filed Against Nano-X Imaging Ltd. Over Securities Violations
- Class Action Initiation: Pomerantz LLP has filed a class action lawsuit against Nano-X Imaging Ltd. in New Jersey on behalf of investors who purchased securities between March 31, 2025, and April 17, 2026, seeking damages for violations of federal securities laws, highlighting a significant trust crisis among investors regarding the company's management.
- Financial Loss Disclosure: On April 20, 2026, Nano-X reported a Q4 net loss of $33.4 million, including a $17.5 million impairment charge, indicating severe financial challenges during its restructuring process, which may further erode investor confidence.
- Executive Turnover Impact: The announcement of CFO Ran Daniel's resignation effective July 31, 2026, raises concerns about the company's leadership stability, potentially exacerbating market worries about its operational and financial health, which could negatively affect stock performance.
- Stock Price Volatility: Following the earnings report, Nano-X's stock price fell by $0.695, or 24.39%, closing at $2.155, reflecting a pessimistic market sentiment regarding the company's future prospects and possibly prompting further investor withdrawals.
See More
Nano-X Imaging Reports Q1 2026 Revenue Miss and Withdraws Outlook
- Revenue Shortfall: Nano-X Imaging reported Q1 2026 revenue of $4.3 million, missing consensus by $240,000, despite a year-over-year growth of approximately 54%, leading to a premarket stock drop of about 24% as investor expectations were not met.
- Widening Net Loss: The company's net loss widened by approximately 8% year-over-year to $14.3 million, primarily due to a $900,000 increase in operating expenses, even as its gross loss margin improved from 108% to 60%, indicating ongoing cost control challenges.
- Negative Cash Flow: The operational cash flow turned negative at $14.0 million in Q1, with cash and cash equivalents declining 26% year-over-year to $44.3 million, raising concerns about the company's ability to sustain operations for at least the next 12 months.
- Uncertain Outlook: Nano-X Imaging withdrew its full-year revenue outlook of $35 million, citing variability in system deployments and service executions that could impact revenue recognition timing, further intensifying market doubts about its going concern status.
See More
Nano-X Imaging Reports Q1 Earnings with Significant Revenue Growth
- Earnings Highlights: Nano-X Imaging reported a Q1 GAAP EPS of -$0.20, aligning with market expectations, indicating stability in its financial performance.
- Revenue Surge: The company achieved revenue of $4.31 billion in Q1, marking a staggering year-over-year increase of 152736.9%, surpassing analyst forecasts and demonstrating robust business growth momentum.
- Market Reaction: Despite the strong earnings report, Nano-X Imaging's shares fell 3% in after-hours trading, reflecting market caution regarding future growth prospects.
- Investment Outlook: Analysts suggest that while the current stock price is deemed “too cheap to ignore,” investors should remain cautious about timing their entry due to uncertainties surrounding the company's future developments.
See More
Class Action Filed Against Nano-X for Misleading Statements
- Class Action Initiated: Bragar Eagel & Squire, P.C. has filed a class action lawsuit against Nano-X Imaging Ltd. in New Jersey on behalf of investors who purchased securities between March 31, 2025, and April 17, 2026, indicating strong investor dissatisfaction with the company's misleading statements.
- Allegations of Misrepresentation: The lawsuit alleges that Nano-X made false statements regarding operational efficiency and product demand, leading to significantly increased operating expenses and cash burn, which may necessitate restructuring and impairment charges, thereby impacting the company's future financial stability.
- Financial Loss Disclosure: Nano-X reported a net loss of $33.4 million for Q4 2025 on April 20, 2026, including a $17.5 million impairment charge due to restructuring at its Korean chip manufacturing facility, reflecting a deterioration in the company's financial condition.
- Stock Price Volatility: Following the earnings report, Nano-X's stock price plummeted from $2.85 on April 17, 2026, to $2.15, a decline of approximately 25%, indicating market pessimism regarding the company's outlook.
See More
Nano-X Faces Securities Class Action Over Financial Misconduct
- Financial Loss Disclosure: On April 20, 2026, Nano-X reported a quarterly net loss of $33.4 million and a $17.5 million impairment charge, causing its stock to plummet by 24.39% to $2.155, indicating severe deterioration in the company's financial health.
- Rising Operating Expenses: The lawsuit alleges that Nano-X's operating expenses and cash burn escalated significantly at its South Korean manufacturing facility, with management failing to disclose this trend, leading to investor misconceptions about the company's financial stability.
- Lack of Transparency: Nano-X's financial disclosures reportedly misrepresented the true state of cost control, as management's reassurances did not align with actual operational conditions, potentially depriving investors of critical information for informed decision-making.
- Legal Accountability Issues: Under SEC regulations, Nano-X's management had a duty to disclose known trends likely to have a material adverse impact on financial results, and their failure to do so may expose the company to legal liabilities.
See More
